San Diego-based Accelrys Inc., a developer of research management software, has partnered with Solana Beach-based eMolecules Inc. to grow its online directory that helps researchers source chemical compounds.

Following the announcement, stocks rose 14 cents to $9.89 per share by market close for Accelrys, a publicly traded company with a market capitalization of $550 million.

The Accelrys Available Chemicals Directory, or Accelrys ACD, has been used for more than 25 years by researchers. It lists the availability and pricing information for 7.8 million chemical compounds from 940 suppliers, it said in a statement.

"Now, with the inclusion of validated and curated compound availability information from eMolecules, Accelrys ACD customers can order with increased confidence that chemical suppliers will deliver the compounds on time," Matt Hahn, senior vice president and chief technology officer of Accelrys, said in a statement. "Together, Accelrys and eMolecules are revolutionizing the efficiency and reliability of compound acquisition throughout our shared markets."

-SDBJ Staff Report